Skip to main content

Table 5 Anticancer activity of biological metal nanoparticles

From: Biogenic nanoparticles: a comprehensive perspective in synthesis, characterization, application and its challenges

Biological agent used for synthesis Nanoparticle Cell line IC50 value Reference
Marsilea quadrifolia Silver Human ovarian teratocarcinoma (PA-1) and lung adenocarcinoma (A549) 45.88 μg/mL and 52.015 μg/mL [25]
Morinda pubescens Silver HEP G2 (Human Epithelium cells of liver cancer 937 μg/mL [129]
Nepeta deflersiana Silver Human cervical cancer cells (HeLa) 5 μg/mL [130]
Murraya koenigii Silver HT-29 colon cancer 26.05 μg/mL [131]
Cyanobacterium Nostoc sp. strain HKAR-2. Silver MCF-7 cells 27.5 μg/mL. [132]
Piper nigrum Silver MCF-7 and Hep-2 cells 52 mL, 54 μg/mL [133]
Ficus religiosa Silver A549 and Hep2 cells 1.9 μg/mL and 1.6 μg/mL [134]
Solanum xanthocarpum Gold HCT 15 human colon cancer [135]
Streptomyces sp. Gold HeLa 350 μg/mL [136]
Evolvulus alsinoides Palladium Human ovarian cancer A2780 cells [137]
Gloriosa superb Platinum and palladium MCF-7 (human breast adenocarcinoma 49.65 ± 1.99% and 36.26 ± 0.91% [138]
Barleria prionitis Platinum
Paladium
Human breast adenocarcinoma (MCF-7) [139]
Sargassum muticum Iron oxide nanoparticles HeLa cells, MCF-7 cells, HepG2 cells, and human cell lines for leukemia Jurkat 1.1 μg/mL (HepG2), 18.75 ± 2.1 μg/mL (MCF-7), 12.5 ± 1.7 μg/mL (HeLa), and 6.4 ± 2.3 μg/mL (Jurkat) [140]
Albizia lebbeck Zinc oxide MDA-MB 231 and MCF-7 48.5, 48.7, and 60.2 μg/mL [107]
Costus pictus D. Don medicinal Zinc oxide DLA [63]
black bean extract Copper oxide HeLa [115]
Ficus religiosa Copper oxide A549 cells 200 μg/mL [127]